NCT06016374 (TELERE) is a NA clinical trial of telerehabilitation in Brain Injury, Vascular, sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain.

Who is sponsoring NCT06016374?

NCT06016374 is sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain.

What drugs are being tested in NCT06016374?

Interventions in NCT06016374: telerehabilitation.

What condition does NCT06016374 study?

NCT06016374 studies Brain Injury, Vascular, Hemorrhagic Stroke, Ischemic Stroke.

Is NCT06016374 still recruiting?

NCT06016374 is currently recruiting now. Last updated 17 April 2024.

Last reviewed 2024-04-17 · How we verify

NCT06016374: TELERE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Development and Validation of a Structured Tele-rehabilitation Programme of Brain Injured Patients

Recruiting now NA Last updated 17 April 2024

What this trial tests

NA trial testing telerehabilitation in Brain Injury, Vascular in 50 participants. Currently enrolling.

Timeline

21 February 2023

Primary endpoint
1 July 2024

31 December 2024

Quick facts

Lead sponsor	Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	50
Start date	21 February 2023
Primary completion	1 July 2024
Estimated completion	31 December 2024
Sites	1 location across Belgium

Drugs / interventions tested

telerehabilitation

Conditions studied

Brain Injury, Vascular — all drugs for Brain Injury, Vascular →
Hemorrhagic Stroke — all drugs for Hemorrhagic Stroke →
Ischemic Stroke — all drugs for Ischemic Stroke →

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain — full company profile →

Who can join

18 and older, any sex, with Brain Injury, Vascular or Hemorrhagic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this research project is to develop a tele-rehabilitation programme, which will constitute an original care pathway for brain damaged patients. It will aim to improve their impairments, activities and social participation. The programme will deliver a therapeutic education and self-education programme targeting the upper and lower limbs, and will assess the patients by means of a diary and self-evaluation questionnaires.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Developing an mHealth App-based Telerehabilitation Programme for Stroke Survivors: A Feasibility and Usability Study.
Van Durme M, Lejeune T, Stoquart G, Dehem S. · · 2025 · PMID 40432510 · DOI 10.1177/10538135251344925

Verify or expand the search:

Other trials of telerehabilitation

Trials testing the same drug.

NCT07502573 — Telerehabilitation vs. Home Exercise in Piriformis Syndrome: A Comparative Study · NA · enrolling by invitation
NCT06957522 — Comparison of the Effectiveness of Face to Face Rehabilitation and Telerehabilitation in Infants With Congenital Muscula · NA · not yet recruiting
NCT06327555 — Comparison of the Efficacy of Telerehabilitation and In-person Rehabilitation Based on Wearable Devices After ACLR Surge · NA · completed
NCT06804317 — Effectiveness of a Supervised Multicomponent Exercise-Based Telerehabilitation Intervention on Physical Performance in O · NA · completed
NCT06095336 — Telerehabilitation and Conventional Physiotherapy Program for Caregivers of Individuals With Special Needs · NA · unknown

Other recruiting trials for Brain Injury, Vascular

Currently open trials in the same condition.

NCT06898242 — Early Myofascial Manual Treatment in Subjects With Spasticity Following Acquired Brain Injury · NA · active not recruiting

Other Cliniques universitaires Saint-Luc- Université Catholique de Louvain trials

Trials by the same sponsor.

NCT07464938 — New Tools and Predictive Markers in the Prognosis of Hypoxic-ischemic Encephalopathy Following Cardiac Arrest · NA · recruiting
NCT07173036 — Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification Accordin · NA · not yet recruiting
NCT07245745 — Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer · NA · recruiting
NCT07588490 — Treatment of Acute Low Back Pain With Transcutaneous Electrical Neurostimulation in Emergency Departments · NA · recruiting
NCT07161219 — Implementation of New Exercise Protocols in Cardiac Rehabilitation. · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06016374 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Last refreshed: 17 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06016374.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing